Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 20/20 | 0.89 |
| ▸ | BACE2 | Q9Y5Z0 | 19/20 | 0.89 |
| ▸ | CTSD | P07339 | 18/20 | 0.89 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5258763 | 0.95 | BACE1 (0.90) | BACE1BACE2CTSD | |
| SCHEMBL5224624 | 0.94 | BACE1 (1.00) | BACE1BACE2CTSD | |
| SCHEMBL5221823 | 0.94 | BACE1 (0.77) | BACE1BACE2CTSD | |
| SCHEMBL5218415 | 0.94 | BACE1 (0.90) | BACE1BACE2CTSD | |
| Hydrochloric Acid SCHEMBL5225675 | 0.93 | BACE1 (0.98) | BACE1BACE2CTSD | |
| SCHEMBL5217848 | 0.92 | BACE1 (0.88) | BACE1BACE2CTSD | |
| SCHEMBL5256430 | 0.92 | BACE1 (0.84) | BACE1BACE2CTSD | |
| SCHEMBL5221615 | 0.91 | BACE1 (0.91) | BACE1BACE2CTSD | |
| SCHEMBL5222839 | 0.91 | BACE1 (0.91) | BACE1BACE2CTSD | |
| SCHEMBL5219214 | 0.91 | BACE1 (0.85) | BACE1BACE2CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567488-B1 | HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | GLAXO GROUP LTD (GB) | 2007-02-21 | — | — | EP | claimed |
| EP-1567488-B1 | HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | GLAXO GROUP LTD (GB) | 2007-02-21 | — | — | EP | disclosed |